Safety Profile of Levetiracetam
- 1 August 2001
- Vol. 42 (s4) , 36-39
- https://doi.org/10.1111/j.1528-1167.2001.00008.x
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Long-term continuation of levetiracetam in patients with refractory epilepsyNeurology, 2001
- Efficacy and Tolerability of Levetiracetam 3000 mg/d in Patients with Refractory Partial Seizures: A Multicenter, Double‐Blind, Responder‐Selected Study Evaluating MonotherapyEpilepsia, 2000
- Multicenter Double‐Blind, Randomized, Placebo‐Controlled Trial of Levetiracetam as Add‐On Therapy in Patients with Refractory Partial SeizuresEpilepsia, 2000
- Levetiracetam for partial seizuresNeurology, 2000
- A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsySeizure, 2000